You mean until the ceo's financial security is secured for years to come under the guise of promoting new vaccine development. Watch for the new insider options that will be granted this May. Also Vijay's new friends, UBS, Credit Sw etc. will vote his way to ok these options. Disgusting, but how can you stop these bums?
I'll reserve judgement on the CEO until the A-7 PIII trial is completed. If that can be successfully concluded and the new money is earmarked for initiating Herpe trials, I have no problem having him on the job. I am not a day trader, so short-term reaction to the news doesn't bother me, but give me opportunity to increase my position, if the fundamentals remain positive. So far the VICL has my confidence as a long term investment.